HIV Clinical Mini-Residency Preceptorship Training


Date: Apr 26, 2024 09:15 AM - 01:15 PM

Fee

$0.00

CE Hours

4.00

CE Units

0.400

Registration closes on May 17, 2024 01:00 AM

Activity Type

Knowledge

Target Audience(s)

Pharmacists

Accreditation(s)

Accreditation Council for Pharmacy Education
Accreditation Statement: Howard University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

 

Registration closes on May 17, 2024 at 01:00 AM

Registration Closed  

Objectives

  • Define the principles of perinatal HIV exposure and transmission.
  • Describe the epidemiology of perinatal HIV infection in the USA and Washington, DC
  • Explain how to identify HIV infection in mothers, neonates, and infants
  • Describe the principles of perinatal antiretroviral therapy for the prevention of mother-to-child transmission.
  • Describe the current recommendations for the approach to infant feeding choices among mothers living with HIV

Speaker(s)/Author(s)

Natella Rakhmanina, MD., Ph.D, Professor of Pediat, MD, Ph.D.
Children's National Health System

Activity Number

0010-0000-24-017-L02-P
Date: 04/26/24
Time: 09:05 AM - 10:15 AM

CE Hours

1.00
Registration Closed  

Registration Closed  

Objectives

  • Define the terms related to the LGBTQ+ community, with a particular emphasis on those who are transgender and gender non-conforming.
  • Recognize the types of gender-affirming medical interventions transgender and gender non-conforming persons may undergo as well as the physiological changes that may occur during gender-affirming treatment.
  • Recall many of the social and environmental stressors persons who identify as transgender and non-conforming persons may experience, particularly those with HIV.
  • Describe opportunities to improve access and quality of health care for transgender and gender non-conforming patients with and without HIV

Speaker(s)/Author(s)

Maya Leiva, PharmD
APP Clinical Pharmacy Specialist-Hematology and Oncology, Inova Schar Cancer Institute

Activity Number

0010-0000-24-018-L02-P
Date: 04/26/24
Time: 10:15 AM - 11:05 AM

CE Hours

1.00
Registration Closed  

Registration Closed  

Objectives

  • Describe required screenings to initiate primary care for an HIV-positive individual.
  • Describe routine tests to optimize HIV patients’ care.
  • Describe preventive medical screening for HIV-positive patients

Speaker(s)/Author(s)

Micheal Serlin, MD

Activity Number

0010-0000-24-019-L02-P
Date: 04/26/24
Time: 11:15 AM - 12:15 PM

CE Hours

1.00
Registration Closed  

Registration Closed  

Objectives

  • Discuss the use of PrEP (pre-exposure prophylaxis) for the prevention of HIV transmission.
  • Explain strategies for appropriate screening for PrEP across a variety of practice settings.
  • Discuss the potential considerations for individualizing PrEP based on patient and medication characteristics

Speaker(s)/Author(s)

Kyle Melin, Pharm.D.

Activity Number

0010-0000-24-020-L02-P
Date: 04/26/24
Time: 12:15 PM - 01:15 PM

CE Hours

1.00
Registration Closed